Funding
Series C · Biotech

bit.bio raises $50M Series C

bit.bio raised $50 million in Series C financing announced in January, with M&G Investments among its backers.

Updated Oct 16, 2026By RoundOS Funding desk

The company develops human cells and models for research, drug discovery and development.

Funding history

Series C · This round$50M

Sources

  1. bit.bioprojectstartups.com
  2. prnewswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related